Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $12.2 million.

  • Exponent's Change in Accured Expenses rose 31511.86% to $12.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.6 million, marking a year-over-year increase of 16063.22%. This contributed to the annual value of $495000.0 for FY2025, which is 10979.23% up from last year.
  • According to the latest figures from Q4 2025, Exponent's Change in Accured Expenses is $12.2 million, which was up 31511.86% from $3.8 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Change in Accured Expenses registered a high of $29.6 million during Q3 2021, and its lowest value of -$29.6 million during Q1 2024.
  • For the 5-year period, Exponent's Change in Accured Expenses averaged around $610100.0, with its median value being $4.1 million (2022).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 89671.23% in 2021, then plummeted by 6569.39% in 2025.
  • Quarter analysis of 5 years shows Exponent's Change in Accured Expenses stood at $14.6 million in 2021, then rose by 21.67% to $17.7 million in 2022, then tumbled by 54.43% to $8.1 million in 2023, then plummeted by 63.44% to $2.9 million in 2024, then soared by 315.12% to $12.2 million in 2025.
  • Its Change in Accured Expenses was $12.2 million in Q4 2025, compared to $3.8 million in Q3 2025 and -$27.6 million in Q2 2025.